178 related articles for article (PubMed ID: 30338800)
21. MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells.
Chen Y; Feng F; Gao X; Wang C; Sun H; Zhang C; Zeng Z; Lu Y; An L; Qu J; Wang F; Yang Y
Curr Cancer Drug Targets; 2015; 15(3):176-87. PubMed ID: 25714700
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.
Chang S; Chen B; Wang X; Wu K; Sun Y
BMC Cancer; 2017 Apr; 17(1):248. PubMed ID: 28388883
[TBL] [Abstract][Full Text] [Related]
23. Expression and significance of PTEN and miR-92 in hepatocellular carcinoma.
Zhao B; Zhu Y; Cui K; Gao J; Yu F; Chen L; Li S
Mol Med Rep; 2013 May; 7(5):1413-6. PubMed ID: 23546593
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
25. MiR-371 promotes proliferation and metastasis in hepatocellular carcinoma by targeting PTEN.
Wang H; Zhao Y; Chen T; Liu G; He N; Hu H
BMB Rep; 2019 May; 52(5):312-317. PubMed ID: 30940319
[TBL] [Abstract][Full Text] [Related]
26. MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN.
Yan SY; Chen MM; Li GM; Wang YQ; Fan JG
Tumour Biol; 2015 Jun; 36(6):4747-55. PubMed ID: 25647261
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
Cheng J; Wu LM; Deng XS; Wu J; Lv Z; Zhao HF; Yang Z; Ni Y
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):336-344. PubMed ID: 30108016
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.
Zhang Q; Zhao S; Pang X; Chi B
Oncol Rep; 2016 Mar; 35(3):1831-40. PubMed ID: 26677080
[TBL] [Abstract][Full Text] [Related]
29. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.
Zhang JG; Shi Y; Hong DF; Song M; Huang D; Wang CY; Zhao G
Sci Rep; 2015 Jan; 5():8087. PubMed ID: 25627001
[TBL] [Abstract][Full Text] [Related]
30. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-383 inhibits proliferation, migration, and invasion in hepatocellular carcinoma cells by targeting PHF8.
Cheng Y; Liu N; Yang C; Jiang J; Zhao J; Zhao G; Chen F; Zhao H; Li Y
Mol Genet Genomic Med; 2020 Aug; 8(8):e1272. PubMed ID: 32441881
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA Linc01296 promotes hepatocellular carcinoma development through regulation of the miR-26a/PTEN axis.
Zhang L; Hu J; Hao M; Bu L
Biol Chem; 2020 Feb; 401(3):407-416. PubMed ID: 31318685
[TBL] [Abstract][Full Text] [Related]
36. [Growth inhibition of human hepatocellular carcinoma by miRNA-204 via down-regulation of Bcl-2 and Sirt1 expression].
Li K; Xyu Q; Liu X; Liu Q; Wang M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):168-72. PubMed ID: 25652855
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
Tan W; Lim SG; Tan TM
World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
[TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNA MALAT1 Regulates Hepatocellular Carcinoma Growth Under Hypoxia via Sponging MicroRNA-200a.
Zhao ZB; Chen F; Bai XF
Yonsei Med J; 2019 Aug; 60(8):727-734. PubMed ID: 31347327
[TBL] [Abstract][Full Text] [Related]
39. Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.
Lv X; Li J; Yang B
Oncol Rep; 2016 Oct; 36(4):2184-92. PubMed ID: 27498785
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of sevoflurane in HCC cell line is mediated by miR-29a-induced suppression of Dnmt3a.
Song G; Tian L; Cheng Y; Liu J; Wang K; Li S; Li T
J Cell Biochem; 2019 Oct; 120(10):18152-18161. PubMed ID: 31190353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]